EGFR Positive Non-small Cell Lung Cancer

Showing NaN - NaN of 1

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

EGFR Positive NSCLC, Adenocarcinoma Trial in Beijing (Icotinib, Placebo)

Unknown status
  • EGFR Positive Non-small Cell Lung Cancer
  • Adenocarcinoma
  • Beijing, Beijing, China
  • +10 more
Jul 12, 2018